2023 - Research.com Medicine in Netherlands Leader Award
The scientist’s investigation covers issues in Radiation therapy, Nuclear medicine, Lung cancer, Positron emission tomography and Internal medicine. Philippe Lambin has researched Radiation therapy in several fields, including Cancer and Prospective cohort study, Pathology. His Nuclear medicine study integrates concerns from other disciplines, such as Survival analysis, Primary tumor and Radiology.
His work is dedicated to discovering how Lung cancer, Stage are connected with Lung and other disciplines. His research in Positron emission tomography intersects with topics in Tomography and Medical imaging. His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His primary scientific interests are in Radiation therapy, Nuclear medicine, Internal medicine, Oncology and Radiology. The various areas that Philippe Lambin examines in his Radiation therapy study include Stage, Lung cancer, Medical physics and Chemotherapy. Specifically, his work in Lung cancer is concerned with the study of Non small cell.
His Nuclear medicine study incorporates themes from Radiation treatment planning, Carcinoma and Colorectal cancer. Internal medicine is frequently linked to Pathology in his study. His research in Radiology is mostly concerned with Radiomics.
His primary areas of investigation include Radiation therapy, Internal medicine, Radiomics, Oncology and Radiology. His study in Radiation therapy is interdisciplinary in nature, drawing from both Positron emission tomography, Lung cancer, Hypoxia and Immunotherapy. His study explores the link between Hypoxia and topics such as Prodrug that cross with problems in Cancer research.
His Radiomics research is multidisciplinary, incorporating perspectives in Medical imaging, Medical physics, Lung, Predictive value and Receiver operating characteristic. His study on Oncology also encompasses disciplines like
His main research concerns Radiation therapy, Internal medicine, Oncology, Radiomics and Nuclear medicine. His Radiation therapy research incorporates elements of Magnetic resonance imaging, Clinical trial and Therapeutic index. Many of his research projects under Internal medicine are closely connected to Animation with Animation, tying the diverse disciplines of science together.
Philippe Lambin is involved in the study of Oncology that focuses on Lung cancer in particular. The subject of his Radiomics research is within the realm of Radiology. His Nuclear medicine research integrates issues from Histogram, Prostate, Prostate cancer and Receiver operating characteristic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Hugo J W L Aerts;Emmanuel Rios Velazquez;Ralph T H Leijenaar;Chintan Parmar.
Nature Communications (2014)
Radiomics: extracting more information from medical images using advanced feature analysis.
Philippe Lambin;Emmanuel Rios-Velazquez;Ralph Leijenaar;Sara Carvalho.
European Journal of Cancer (2012)
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin;Ralph T H Leijenaar;Timo M Deist;Jurgen Peerlings.
Nature Reviews Clinical Oncology (2017)
Carbonic anhydrase inhibitors
Peter Ebbesen;Claudlu T. Supuran;Andrea Scozzafava;Erik Olai Pettersen.
Medicinal Research Reviews (2011)
Radiomics: the process and the challenges
Virendra Kumar;Yuhua Gu;Satrajit Basu;Anders Berglund.
Magnetic Resonance Imaging (2012)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
Alex Zwanenburg;Alex Zwanenburg;Martin Vallières;Mahmoud A. Abdalah;Hugo J. W. L. Aerts;Hugo J. W. L. Aerts.
Tailoring the atomic structure of graphene nanoribbons by scanning tunnelling microscope lithography
Levente Tapasztó;Gergely Dobrik;Philippe Lambin;László P. Biró.
Nature Nanotechnology (2008)
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
Kasper M.A. Rouschop;Twan van den Beucken;Ludwig Dubois;Hanneke Niessen.
Journal of Clinical Investigation (2010)
Machine Learning methods for Quantitative Radiomic Biomarkers
Chintan Parmar;Chintan Parmar;Patrick Grossmann;Johan Bussink;Philippe Lambin.
Scientific Reports (2015)
Low-dose hypersensitivity : Current status and possible mechanisms
Michael C Joiner;Brian Marples;Philippe Lambin;Susan C Short.
International Journal of Radiation Oncology Biology Physics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: